By: Lucio III, Oliverson, Metcalf H.B. No. 1586
A BILL TO BE ENTITLED
AN ACT
relating to health benefit plan coverage of clinician-administered
drugs.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Chapter 1369, Insurance Code, is amended by
adding Subchapter L to read as follows:
SUBCHAPTER L. CLINICIAN-ADMINISTERED DRUGS
Sec. 1369.551. DEFINITIONS. In this subchapter:
(1) "Administer" means to directly apply a drug to the
body of a patient by injection, inhalation, ingestion, or any other
means.
(2) "Clinician-administered drug" means an outpatient
prescription drug other than a vaccine that:
(A) cannot reasonably be:
(i) self-administered by the patient to
whom the drug is prescribed; or
(ii) administered by an individual
assisting the patient with the self-administration; and
(B) is typically administered:
(i) by a physician or other health care
provider authorized under the laws of this state to administer the
drug, including when acting under a physician's delegation and
supervision; and
(ii) in a physician's office, hospital
outpatient infusion center, or other clinical setting.
(3) "Health care provider" means an individual who is
licensed, certified, or otherwise authorized to provide health care
services in this state.
(4) "Physician" means an individual licensed to
practice medicine in this state.
Sec. 1369.552. APPLICABILITY OF SUBCHAPTER. (a) This
subchapter applies only to a health benefit plan that provides
benefits for medical or surgical expenses incurred as a result of a
health condition, accident, or sickness, including an individual,
group, blanket, or franchise insurance policy or insurance
agreement, a group hospital service contract, or an individual or
group evidence of coverage or similar coverage document that is
offered by:
(1) an insurance company;
(2) a group hospital service corporation operating
under Chapter 842;
(3) a health maintenance organization operating under
Chapter 843;
(4) an approved nonprofit health corporation that
holds a certificate of authority under Chapter 844;
(5) a multiple employer welfare arrangement that holds
a certificate of authority under Chapter 846;
(6) a stipulated premium company operating under
Chapter 884;
(7) a fraternal benefit society operating under
Chapter 885;
(8) a Lloyd's plan operating under Chapter 941; or
(9) an exchange operating under Chapter 942.
(b) Notwithstanding any other law, this subchapter applies
to:
(1) a small employer health benefit plan subject to
Chapter 1501, including coverage provided through a health group
cooperative under Subchapter B of that chapter;
(2) a standard health benefit plan issued under
Chapter 1507;
(3) health benefits provided by or through a church
benefits board under Subchapter I, Chapter 22, Business
Organizations Code;
(4) group health coverage made available by a school
district in accordance with Section 22.004, Education Code;
(5) a regional or local health care program operating
under Section 75.104, Health and Safety Code; and
(6) a self-funded health benefit plan sponsored by a
professional employer organization under Chapter 91, Labor Code.
(c) This subchapter does not apply to an issuer or provider
of health benefits under or a pharmacy benefit manager
administering pharmacy benefits under a workers' compensation
insurance policy or other form of providing medical benefits under
Title 5, Labor Code.
Sec. 1369.553. CERTAIN LIMITATIONS ON COVERAGE OF
CLINICIAN-ADMINISTERED DRUGS PROHIBITED. (a) A health benefit plan
issuer may not, for a patient with a cancer or cancer-related
diagnosis:
(1) require a clinician-administered drug to be
dispensed by a pharmacy selected by the health benefit plan issuer;
(2) require that a clinician-administered drug or the
administration of a clinician-administered drug be covered as a
pharmacy benefit rather than a medical benefit;
(3) if a clinician-administered drug is otherwise
covered, limit or exclude coverage for the clinician-administered
drug when not dispensed by a pharmacy selected by the health benefit
plan issuer; or
(4) prohibit a physician or health care provider from
obtaining or administering a clinician-administered drug that the
physician or provider is otherwise permitted to obtain or
administer by law.
(b) Nothing in this section may be construed to:
(1) authorize a person to administer a drug when
otherwise prohibited under the laws of this state or federal law; or
(2) modify drug administration requirements under the
laws of this state, including any requirements related to
delegation and supervision of drug administration.
SECTION 2. Subchapter L, Chapter 1369, Insurance Code, as
added by this Act, applies only to a health benefit plan that is
delivered, issued for delivery, or renewed on or after January 1,
2022.
SECTION 3. This Act takes effect September 1, 2021.